[1] |
MA Fenghua, JIANG Anqi, CHEN Yiqing, XU Congjian, KANG Yu.
Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia
[J]. China Oncology, 2024, 34(4): 380-388.
|
[2] |
CHEN Lijun, WANG Yichen, ZHENG Qiang, WANG Yue, JIN Yan, LI Yuan.
Consistency analysis of PD-L1 immunohistochemistry antibodies in esophageal squamous cell carcinoma
[J]. China Oncology, 2023, 33(5): 469-477.
|
[3] |
CD-Positive Lymphoma Pathology Expert Group.
The standardization of immunohistochemical detection and interpretation of CD30 expression in lymphomas
[J]. China Oncology, 2023, 33(3): 228-234.
|
[4] |
LIU Yanquan, HU Xiaomei, YIN Yue, LIN Lin, SHEN Jianzhen, CHEN Yuting, TANG Huanwen.
A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder
[J]. China Oncology, 2022, 32(7): 650-656.
|
[5] |
WU Quan, GUO Jingwei, LEI Yuxin, HU Xiaoru, WANG Zhe.
Expression of MMR in 515 cases of endometrioid adenocarcinoma and its correlation with clinicopathological features
[J]. China Oncology, 2022, 32(12): 1190-1198.
|
[6] |
XU Ran , WANG Xinyue , FENG Linyuan , HAN Anna , WANG Yixuan , YANG Wanshan , LIU Chao .
Expression and biological significance of NCAPD2 in glioma
[J]. China Oncology, 2021, 31(9): 789-798.
|
[7] |
LIU Wei , WANG Xiaojiang , ZHANG Jing , ZHU Weifeng , PENG Fengying , WANG Jianchao , XIAO Weijin , HU Dan .
Clinicopathological characteristics and prognostic analysis of medullary thyroid carcinoma in children and adolescents
[J]. China Oncology, 2021, 31(11): 1096-1103.
|
[8] |
HUANG Ling , ZOU Yourui , MA Yue , LI Zhuoqi , GAO Xinyi , ABU Lagu , MA Hui .
Expression difference and clinical significance of CHKα in different grades of gliomas
[J]. China Oncology, 2021, 31(10): 892-898.
|
[9] |
WU Yanni , ZHAO Chen .
Solitary fibrous tumor of thyroid: clinicopathologic analysis and literature review
[J]. China Oncology, 2020, 30(6): 462-467.
|
[10] |
WANG Lin , JIA Jing , YE Xingming , LIN Lu , CHEN Yanping , CHEN Ying .
Prognostic significance of histone methyltransferase hSETD1A expression in rectal cancer
[J]. China Oncology, 2020, 30(5): 369-374.
|
[11] |
LI Yuan.
Personalized immunotherapy for lung cancer under the guidance of pathology
[J]. China Oncology, 2020, 30(10): 770-776.
|
[12] |
WANG Yuhang, SONG Quanfu, WU Junqiang, Nading Abiyasi, A Leha, PANG Da, JIANG Yongdong.
FGFR1 protein level is associated with ER expression and prognosis in ER-positive breast cancer
[J]. China Oncology, 2019, 29(5): 345-351.
|
[13] |
MA Jiaqiang, CAO Chunmei, Shyamal Goswami, CHEN Qin, GAO qiang, ZHANG Xiaoming.
Detection of ICOS+ T cells by multiplex immunohistochemistry in tumor tissue and its clinical significance in hepatocellular carcinoma
[J]. China Oncology, 2019, 29(5): 352-361.
|
[14] |
CHEN Junhui, ZHANG Man, LIU Shuipeng, MA Lin, LIU Yang, LI Xiaosong, MENG Jian, LI Jie, ZHANG Shuhua.
The research on risk prediction of thyroid cancer based on ultrasonic characteristic multivariate logistic regression coefficient β composite score method
[J]. China Oncology, 2019, 29(4): 289-293.
|
[15] |
SUN Xiangjie, YANG Wentao.
Issues on immunohistochemistry for molecular classification of breast cancer
[J]. China Oncology, 2019, 29(3): 161-165.
|